Clarke Barlow
Net worth: 3 733 $ as of 30/07/2026
Net worth: 3 733 $ as of 30/07/2026
Clarke Colin Barlow is the founder of AMG Acquisition Corp., founded in 2021, serving as Independent Director since 2021.
Current jobs include Non-Executive Director at Neuroscientific Biopharmaceuticals Ltd. since 2023 and Member at Australian Institute of Co. Directors.
Former jobs include Non-Executive Director at Exopharm Ltd. and Non-Executive Director at Entropy Neurodynamics Ltd. in 2024.
Education includes undergraduate studies at The University of Western Australia.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AMG ACQUISITION CORP. 11.59% | 05/05/2025 | 533,340 ( 11.59% ) | 3 733 $ | 30/07/2026 |
| Companies | Position | Start |
|---|---|---|
| AMG ACQUISITION CORP. | Founder | 31/05/2021 |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Director/Board Member | 16/11/2023 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| EXOPHARM | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd. BiotechnologyHealth Technology Engages in researching and developing pharmaceutical products | Health Technology |
Exopharm Ltd.
Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent | Health Technology |
AMG Acquisition Corp.
AMG Acquisition Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Select your edition
All financial news and data tailored to specific country editions